UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
MARCH 1, 2006
Date of Report (Date of earliest event reported)
CEPHEID
(Exact name of Registrant as specified in its charter)
| | | | | |
| California | | 000-30755 | | 77-0441625 |
| | | | | |
| (State of incorporation) | | (Commission | | (I.R.S. Employer |
| | | file number) | | Identification No.) |
904 Caribbean Drive
Sunnyvale, CA 94089
(Address of principal executive offices, including zip code)
(408) 541-4191
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
ITEM 8.01. OTHER EVENTS.
On March 1, 2006, Cepheid issued a press release announcing that it had submitted its Xpert GBSTM test for Group BStreptococcus(GBS) for use on the GeneXpert System to the U.S. Food & Drug Administration for regulatory clearance. A copy of the press release is attached as Exhibit 99.01 to this current report on Form 8-K and is incorporated by reference herein.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
| | | |
| Number | | Description |
| 99.01 | | Press release dated March 1, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | CEPHEID |
| | | | | |
| Date: March 1, 2006 | | | | |
| | | | | |
| | | By: | | /s/ JOHN R. SLUIS |
| | | | | |
| | | Name: | | John R. Sluis |
| | | Title: | | Senior Vice President, Finance, and |
| | | | | Chief Financial Officer |
EXHIBIT INDEX
| | | |
| Number | | Description |
| 99.01 | | Press Release dated March 1, 2006. |
